Effects of Chinese herbal medicine Xiangbin prescription on gastrointestinal motility

被引:10
作者
Jiang, Zhi [1 ]
Cao, Li-Xing [1 ]
Liu, Bo [1 ]
Chen, Qi-Cheng [1 ]
Shang, Wen-Fan [1 ]
Zhou, Lu [2 ]
Li, Dan-Yan [1 ]
Guo, De-An [3 ]
Chen, Zhi-Qiang [1 ]
机构
[1] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou 510120, Guangdong, Peoples R China
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 201203, Peoples R China
关键词
Antrotroduodenojejunal manometry; Gastrointestinal motility; Migrating motor complex; Xiangbin concoction; Motilin; Ghrelin; MIGRATING MOTOR COMPLEX; MECHANISM; RECEPTOR; GHRELIN; STOMACH; ARECA;
D O I
10.3748/wjg.v23.i16.2987
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the effects of Xiangbin prescription (XBP), a Chinese herbal concoction, on gastrointestinal motility. METHODS Forty healthy volunteers were recruited for this randomized controlled trial of XBP. Antroduodenojejunal manometry was used to monitor gastrointestinal motility in these subjects. After the subjects had fasted for at least 12 h, XBP (n = 30) or placebo (n = 10) was orally administrated and gastrointestinal motility was recorded for 4 h. Plasma motilin and ghrelin were measured by enzyme-linked immunosorbent assay. RESULTS Oral administration of XBP significantly increased the amplitude of duodenal contractions [19.5 (13.0-26.7) vs 16.9 (12.3-23.9), P < 0.05], jejunal contractions [18.3 (15.3-25.0) vs 15.4 (11.7-23.9), P < 0.01], and the motility index of duodenal contractions [522.0 (146.0-139.0) vs 281.0 (76.5-1006.0), P < 0.01] in phase. of the migratory motor complex (MMC), which subsequently initiated the MMC cycle [74.0 (30.0-118.0) vs 116.5 (24.0-219.0), P < 0.05], shortened the duration of phase I of the MMC [42.0 (0.0-90.0) vs 111.5 (42.0-171.0), P < 0.01], and lengthened the duration of phase. of the MMC [120 (21-240) vs 58 (16-170), P < 0.01] compared to the duration before XBP administration. There were significant differences in the amplitude of jejunal contractions [19.8 (14.0-30.0) vs 18.0 (13.0-28.5), P < 0.05], the motility index of duodenal contractions [236.0 (115.0-306.0) vs 195.0 (109.0-310.0), P < 0.05)], and jejunal contractions [214.0 (95.0-403.0) vs 178.0(55.0-304.0), P < 0.01] in phase. of the MMC. Oral administration of XBP greatly increased plasma motilin (57.69 +/- 9.03 vs 49.38 +/- 8.63, P < 0.01) and ghrelin (279.20 +/- 104.31 vs 238.73 +/- 115.59, P < 0.01) concentrations compared to concentrations after oral administration of the placebo. CONCLUSION XBP can stimulate duodenal and jejunal motility and increase the concentrations of plasma motilin and ghrelin. The clinical applicability of XBP in treating GDIM deserves investigation.
引用
收藏
页码:2987 / 2994
页数:8
相关论文
共 27 条
  • [1] Bouin Mickael, 2004, JPEN J Parenter Enteral Nutr, V28, P169, DOI 10.1177/0148607104028003169
  • [2] Effects of ginsenosides on rat jejunal contractility
    Chen, Dapeng
    Xiong, Yongjian
    Jiang, Chunling
    Lv, Bochao
    Liu, Fangfei
    Wang, Li
    Lin, Yuan
    [J]. PHARMACEUTICAL BIOLOGY, 2014, 52 (02) : 162 - 168
  • [3] Chen ZQ, 2015, J TRADIT CHIN MED, V56, P1953
  • [4] Ciriza-de-los-Ríos Constanza, 2014, Rev. esp. enferm. dig., V106, P22, DOI 10.4321/s1130-01082014000100004
  • [5] INTERDIGESTIVE MYO-ELECTRIC COMPLEX OF STOMACH AND SMALL BOWEL OF DOGS
    CODE, CF
    MARLETT, JA
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1975, 246 (02): : 289 - 309
  • [6] Ghoshal Uday C, 2008, Indian J Gastroenterol, V27, P53
  • [7] Presence of cholinomimetic and acetylcholinesterase inhibitory constituents in betel nut
    Gilani, AH
    Ghayur, MN
    Saify, ZS
    Ahmed, SP
    Choudhary, MI
    Khalid, A
    [J]. LIFE SCIENCES, 2004, 75 (20) : 2377 - 2389
  • [8] Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives
    Jeng, JH
    Chang, MC
    Hahn, LJ
    [J]. ORAL ONCOLOGY, 2001, 37 (06) : 477 - 492
  • [9] Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
    Katz, Philip O.
    Gerson, Lauren B.
    Vela, Marcelo F.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (03) : 308 - 328
  • [10] Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study
    Kidane, Biniam
    Manji, Farouq
    Lam, Jennifer
    Taylor, Brian M.
    [J]. SCIENTIFICA, 2016, 2016